• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

背景食管无卢戈氏碘染色缺损的食管癌的临床特征。

Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.

机构信息

Department of Gastroenterology, Omori Red Cross Hospital, Tokyo, Japan.

Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Kanagawa, Japan.

出版信息

Dig Endosc. 2020 May;32(4):621-627. doi: 10.1111/den.13631. Epub 2020 Mar 20.

DOI:10.1111/den.13631
PMID:31965622
Abstract

Lugol chromoendoscopy is useful for the detection of early esophageal squamous cell cancer (ESCC). Multiple lugol-voiding lesions (LVLs) on lugol chromoendoscopy are associated with a very high risk of multiple cancers arising in the esophagus. Due to the widespread use of narrow band image technology in many institutions, esophageal cancer without LVLs in the background esophagus is sometimes detected. This retrospective study aims to clarify the clinical characteristic of esophageal cancer without LVLs in the background esophagus. A total of 191 consecutive patients with 204 ESCCs had undergone endoscopic submucosal dissection (ESD) from 2011 and 2014. Amongst these lesions, the number of LVLs in the background esophagus per endoscopic view was counted excluding main lesion, and the grading was divided into no LVLs ESCC (nL-ESCC) group and LVLs ESCC (L-ESCC) group. This study evaluated the clinical characteristics and the cumulative incidence of metachronous ESCC after ESD in both groups. Thirty-six patients with 36 lesions and 155 patients with 168 lesions were separated into the nL-ESCC group and L-ESCC group, respectively. On multivariate analysis, the nL-ESCC group was found to be more common in females, who were non-drinkers, or with erosive esophagitis. During follow-up periods, the cumulative incidence of metachronous ESCC at 3-years was 14.4% and 0.00% in the L-ESCC and nL-ESCC groups, respectively (P < 0.01). Our study showed that esophageal cancer without LVLs in the background esophagus was mostly occurred in females, who were non-drinkers, or with erosive esophagitis, which are uncommon features of ESCC.

摘要

卢戈氏染色内镜检查有助于发现早期食管鳞状细胞癌(ESCC)。卢戈氏染色内镜下的多发卢戈氏染色缺损(LVLs)与食管多发癌的发生风险极高相关。由于在许多机构广泛使用窄带成像技术,有时会检测到背景食管中无 LVLs 的食管癌。本回顾性研究旨在阐明背景食管中无 LVLs 的食管癌的临床特征。2011 年至 2014 年,共有 191 例连续患者的 204 例 ESCC 接受了内镜黏膜下剥离术(ESD)。在这些病变中,每个内镜视野背景食管中的 LVL 数量(不包括主病灶)进行计数,并将分级分为无 LVLs ESCC(nL-ESCC)组和 LVLs ESCC(L-ESCC)组。本研究评估了两组患者 ESD 后异时性 ESCC 的临床特征和累积发生率。将 36 例 36 个病灶和 155 例 168 个病灶的 36 例患者和 155 例患者分别分为 nL-ESCC 组和 L-ESCC 组。多因素分析发现,nL-ESCC 组女性更为常见,她们是非饮酒者或伴有腐蚀性食管炎。在随访期间,L-ESCC 组和 nL-ESCC 组的异时性 ESCC 累积发生率分别为 3 年时的 14.4%和 0.00%(P < 0.01)。本研究表明,背景食管中无 LVLs 的食管癌多发生于女性,非饮酒者或伴有腐蚀性食管炎,这些是 ESCC 不常见的特征。

相似文献

1
Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.背景食管无卢戈氏碘染色缺损的食管癌的临床特征。
Dig Endosc. 2020 May;32(4):621-627. doi: 10.1111/den.13631. Epub 2020 Mar 20.
2
Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.食管背景黏膜中存在多处卢戈氏碘染色缺损区的内镜所见。
J Gastroenterol Hepatol. 2019 Feb;34(2):390-396. doi: 10.1111/jgh.14439. Epub 2018 Sep 10.
3
Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.头颈部鳞状细胞癌患者食管鳞状细胞癌和卢戈氏染色缺损的特征。
J Clin Gastroenterol. 2010 Feb;44(2):e27-33. doi: 10.1097/MCG.0b013e3181b31325.
4
ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.乙醇脱氢酶1B(ADH1B)和乙醛脱氢酶2(ALDH2)与食管鳞状细胞癌内镜下黏膜下剥离术后异时性鳞状细胞癌相关。
Cancer Med. 2016 Jul;5(7):1397-404. doi: 10.1002/cam4.705. Epub 2016 Mar 31.
5
Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma.同期性食管鳞癌放化疗的疗效。
Digestion. 2021;102(4):622-629. doi: 10.1159/000510368. Epub 2020 Sep 29.
6
Factors associated with the presence of multiple Lugol-voiding lesions in patients with esophageal squamous-cell carcinoma.食管鳞状细胞癌患者中与多个不染碘病变存在相关的因素。
Dis Esophagus. 2014 Jul;27(5):457-62. doi: 10.1111/j.1442-2050.2012.01429.x. Epub 2012 Sep 25.
7
Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.头颈部癌患者中多个不染碘病变与同步及异时性食管鳞状细胞癌的关联
Gastrointest Endosc. 2002 Oct;56(4):517-21. doi: 10.1067/mge.2002.128104.
8
Metachronous multiple esophageal squamous cell carcinomas and Lugol-voiding lesions after endoscopic mucosal resection.内镜黏膜切除术后的异时性多发性食管鳞状细胞癌和不染碘病变
Endoscopy. 2009 Apr;41(4):304-9. doi: 10.1055/s-0029-1214477. Epub 2009 Apr 1.
9
Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in Taiwan.台湾地区内镜黏膜下剥离术治疗表浅性食管鳞状细胞癌的长期疗效。
BMC Gastroenterol. 2021 Aug 3;21(1):308. doi: 10.1186/s12876-021-01888-1.
10
High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.内镜黏膜下剥离术治疗早期食管鳞癌后肺癌死亡发生率高。
Cancer Med. 2024 May;13(9):e7242. doi: 10.1002/cam4.7242.

引用本文的文献

1
Clinicopathological and genomic features of superficial esophageal squamous cell carcinomas in nondrinker, nonsmoker females.非吸烟、非饮酒女性的表浅性食管鳞癌的临床病理及基因组学特征。
Cancer Med. 2024 Feb;13(4):e7078. doi: 10.1002/cam4.7078.